BioSpace News Archive

Business

GeoVax Ebola Vaccine Study Published in the Atlas of Science

GeoVax Ebola Vaccine Provides Potential for 100% Protection from Single-Dose

March 19, 2019
·
3 min read
Policy

Department of Defense Prostate Cancer Research Program Funding Opportunities for Fiscal Year 2019 (FY19)

The FY19 Defense Appropriation provides $100 million to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.

March 19, 2019
·
3 min read
Business

FDA Places Partial Clinical Hold on AbbVie’s Venclexta-Based Multiple Myeloma Trial

In a Phase III trial, a higher proportion of deaths was observed in the venetoclax arm compared to the control arm of the trial.

March 19, 2019
·
2 min read
·
Alex Keown
Biotech Beach

CalciMedica, Inc. to Present Study Population Profile from its Initial Patient Study of its CRAC Channel Inhibitor CM4620 in Acute Pancreatitis at International Conference

Physicians from several study sites involved in CalciMedica’s initial acute pancreatitis clinical study of its CRAC channel inhibitor CM4620 and CalciMedica, Inc., presented a poster at the 39th International Symposium on Intensive Care and Emergency Medicine being held in Brussels on March 19-22.

March 19, 2019
·
3 min read
Business

Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

Baxter International Inc. announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).

March 19, 2019
·
4 min read
Drug Development

NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study

NeuroVive Pharmaceutical AB today announced that the first healthy volunteer in the company’s KL1333 phase Ia/b study has been screened and will be enrolled into the study.

March 19, 2019
·
4 min read
O’Cannabiz Announces Healthcare and Wellness Forum

Agenda Includes Mental Health, Pediatrics, Opioid Management

March 19, 2019
·
1 min read
Drug Development

I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States

I-Mab Biopharma announced dosing of the first healthy subject in a Phase 1 trial in the U.S. of TJM2, a humanized immunoglobulin G1 antibody targeting granulocyte-macrophage colony-stimulating factor.

March 19, 2019
·
3 min read
Business

Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene

Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card

March 19, 2019
·
15 min read
Business

San Diego Bio Executive Named Oregon Bioscience Association’s New Executive Director

Bozinovic comes from Biocom Institute to join the local bio organization as it turns 30

March 19, 2019
·
5 min read